Terpenyl-purines from the sea

Marine Drugs

Volumn 7, Issue 4, 2009, Pages 833-849

  Gordaliza, Marina ^a  

^a UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

Agelasimine; Agelasine; Ageline; Alkyl purine; Asmarine; Terpene purine; Terpenylpurine

Indexed keywords

1 METHYHERBIPOLINE; 1,3 DIMETHYLISOGUANINE; 3,7 DIMETHYLISOGUANINE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); AGELASIN B; AGELASINE; AGELASINE A; AGELASINE C; AGELASINE D; AGELASINE F; AGELASINE G; AGELASINE H; AGELASINE I; AGELASINE J; AGELASINE K; AGELASINE L; ANTIFOULING AGENT; ANTILEUKEMIC AGENT; ASMARINE; DORIDOSINE; ETHAMBUTOL; ETHIONAMIDE; HERBIPOLINE; ISONIAZID; NATURAL PRODUCT; PURINE DERIVATIVE; RIFAMPICIN; TERPENE DERIVATIVE; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIPROTOZOAL ACTIVITY; BACILLUS SUBTILIS; CANCER CELL CULTURE; CANDIDA ALBICANS; CONCENTRATION RESPONSE; CYCLIZATION; DRUG ACTIVITY; DRUG CYTOTOXICITY; DRUG ISOLATION; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME INHIBITION; ESCHERICHIA COLI; GOLDFISH; MARINE SPECIES; MYCOBACTERIUM TUBERCULOSIS; PLASMODIUM FALCIPARUM; REVIEW; RING CLOSING METATHESIS; SACCHAROMYCES CEREVISIAE; SPONGE (PORIFERA); STAPHYLOCOCCUS AUREUS; VIBRIO COSTICOLA;

MYCOBACTERIUM TUBERCULOSIS; PROTOZOA; RASPAILIA;

EID: 75149155218     PISSN: None     EISSN: 16603397     Source Type: Journal    
DOI: 10.3390/md7040833     Document Type: Review

References (101)

1. Newman, J.; Cragg, G. Natural products in medicinal chemistry. Bioorg. Med. Chem. 2009, 17, 2120.
2. Li, M-Y.; Xiao, O.; Pan, J-Y.; Wu, J. Natural products from semi-mangrove flora: Source, chemistry and bioactivities. Nat. Prod. Rep. 2009, 26, 281-298.
3. Newman, D.J.; Cragg, G.M.; Kingston, D.G.I. Natural products as pharmaceuticals and sources for lead structures. In The Practice of Medicinal Chemistry, 3rd ed.; Wermuth, C.G., Ed.; Academic Press: London, UK, 2003; pp.159-186.
4. Newman, D.J.; Cragg, G.M. Natural products as sources of new drugs over the last 25 years. J. Nat. Prod. 2007, 70, 461-477.
5. Newman, D.J.; Cragg, G.M.; Snader, K.M. Natural products as sources of new drugs over the period 1981-2002. J. Nat. Prod. 2003, 66, 1022-1037.
6. Ganesan, A. The impact of natural products upon modern drug discovery. Curr. Opin. Chem. Biol. 2008, 12, 306-317.
7. Newman, D.J. Natural products as leads to potential drugs: An old process or the new hope for drug discovery. J. Med. Chem. 2008, 51, 2589-2599.
8. Galm, U.; Shen, B. Natural products drug discovery: The times have never been better. Chem. Biol. 2007, 14, 1098-1104.
9. Paterson, I.; Anderson, E.A. The renaissance of natural products as drug candidates. Science 2005, 310, 451-453.
10. Harvey, A.L. Natural products as a screening resource. Curr. Opin. Chem. Biol. 2007, 11, 480-484.
11. Rishton, G.M. Natural products as a robust source of new drugs and drug leads: Past successes and present day issues. Am. J. Cardiol. 2008, 101 (Suppl.), 43D-49D.
12. Lam, K.S. New aspects of natural products in drug discovery. Trends Microbiol. 2007, 15, 279-289.
13. Harvey, A.L. Natural product in drug discovery. Drug Discov. Today 2008, 13, 894-901.
14. Butler, M.S. Natural product to drug: Natural products derived compounds in clinical trials. Nat. Prod. Rep. 2008, 25, 475-516.
15. Butler, MS. Natural products to drugs: Natural products derived compounds in clinical trials. Nat. Prod. Rep. 2005, 22, 162-195.
16. Wilson R.M.; Danishefsky, S.J. Small molecule natural products in the discovery of therapeutic agents: The synthesis connection. J. Org. Chem. 2006, 71, 8329-8351.
17. Shaw, J.T. Naturally diverse: Highlights in versatile synthetic methods enabling target and diversity oriented synthesis. Nat. Prod. Rep. 2009, 26, 11-26.
18. Langer, T.; Laggner, C.; Rollinger, J.M.; Stuppner, H. Pharmacophore-based screening for the successful identification of bio-active natural products. Chimia 2007, 61, 350-354.
19. Gordaliza, M. Natural products as leads to anticancer drugs. Clin Transl. Oncol. 2007, 9, 767-776.
20. Pla, D.; Marchal, A.; Olsen, C.A.; Albericio, F.; Álvarez, M. Modular total synthesis of lamellarin D. J. Org. Chem. 2005, 70, 8231-8234.
21. Blunt, J.W.; Copp, B.R.; Hu, W-P.; Munro, M.H.G.; Northcote, P.T.; Prinsep, M.R. Marine natural products. Nat. Prod. Rep. 2009, 26, 170-244.
22. Morris, J.C.; Phillips, A.J. Marine natural products: Synthetic aspects. Nat. Prod. Rep. 2009, 26, 245-265.
23. Skropeta, D. Deep-sea natural products. Nat. Prod. Rep. 2008, 25, 1131-1166.
24. Haefner, B. Drugs from the deep: Marine natural products as drug candidates. Drug Discov. Today 2003, 8, 536-544.
25. Mayer, A.M.S.; Gustafson, K.R. Marine pharmacology in 2005-2006: Antitumour and cytotoxic compounds. Eur. J. Cancer 2008, 44, 2357-2387.
26. Mayer, A.M.S.; Rodríguez, A.D.; Berlinck, R.G.S.; Hamann, M.T. Marine pharmacology in 2005-6: Marine compounds with anthelmintic, antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems, and other miscellaneous mechanisms of action. Biochim. Biophys.-Gen. 2009, 1790, 283-308.
27. Cuevas, C.; Francesch, A. Development of Yondelis® (trabectedin, ET-743). A semisynthetic process solves the supply problem. Nat. Prod. Rep. 2009, 26, 322-333.
28. Glaser, K.B.; Mayer, A.M.S. A renaissance in marine pharmacology: From preclinical curiosity to clinical reality. Biochem. Pharmacol. 2009, 78, 440-448.
29. Molinski, T.F.; Dalisay, D.S.; Lievens, S.L.; Saludes, J.P. Drug development from marine natural products. Nat. Rev. Drug Discov. 2009, 8, 69-85.
30. Bugni, T.S.; Richads, B.; Bhoite, L.; Cimbora, D.; Harper, M.K.; Ireland, C.M. Marine natural product libraries for high-throughput screening and rapid drug discovery. J. Nat. Prod. 2008, 71, 1095-1598.
31. Gordaliza, M.; Miguel del Corral, J.M.; Mahiques, M.M.; San Feliciano, A.; García-Grávalos, M.D. Terpenequinone with antitumor activity. PCT Int. Appl. EP 0731078 A1, 1994.
32. Esteban, G.; Rincón, R.; Csákÿ, A.G.; Plumet, J. A convenient synthesis of the central core of helioporins, seco-pseudopterosins and pseudopterosins via BCA-annulation sequence. Nat. Prod. Comm. 2008, 3, 495-504.
33. Pla, D.; Albericio, F.; Alvarez, M. Recent advances in lamellarin alkaloids: Isolation, synthesis and activity. Anti-Cancer Agents Med. Chem. 2008, 8, 746-760.
34. Vik, A.; Hedner, E.; Charnock, C.; Tangen, L.W.; Samuelsen, O.; Larsson, R.; Bohlin. L.; Gundersen, L.-L. Antimicrobial and cytotoxic activity of agelasine and agelasimine analogs. Bioorg. Med. Chem. 2007, 15, 4016-4037.
35. Capon, R.J.; Faulkner, D.J. Antimicrobial metabolites from a Pacific sponge, Agelas sp. J. Am. Chem. Soc. 1984, 106, 1819-1822.
36. Pappo, D.; Shimony, S.; Kashman, Y. Synthesis of 9-substituted tetrahydrodiazepinopurines: Studies toward the total synthesis of asmarines. J. Org. Chem. 2005, 70, 199-206.
37. Ishida, K.; Ishibashi, M.; Shigemori, H.; Sasaki, T.; Kobayashi, J. Agelasine G, a new antileukemic alkaloid from the Okinawan marine sponge Agelas sp. Chem. Pharm. Bull. 1992, 40, 766-767.
38. Yosief, T.; Rudi, A.; Kashman, Y. Asmarines A-F, novel cytotoxic compounds from the marine sponge Raspailia species. J. Nat. Prod. 2000, 63, 299-304.
39. Gademann, K.; Kobylinska, J. Antimalarial natural products of marine and freshwater origin. Chem. Rec. 2009, 9, 187-198.
40. Vik, A.; Proszenyak, A.; Vermeersch, M.; Cos, P.; Maes, L.; Gundersen, L-L. Screening of agelasine D and analogs for inhibitory activity against pathogenic protozoa; identification of hits for visceral leishmaniasis and chagas disease. Molecules 2009, 14, 279-288.
41. Bakkestuen, A.K.; Gundersen, L-L.; Petersen, D.; Utenova, B.T.; Vik, A. Synthesis and antimycobacterial activity of agelasine E and analogs. Org. Biomol. Chem. 2005, 3, 1025-1033.
42. Kobayashi, M.; Nakamura, H.; Wu, H.; Kobayashi, J.; Ohizumi, Y. Mode of inhibition of brain sodium-potassium ATPase by agelasidines and agelasines from a sea sponge. Arch. Biochem. Biophys. 1987, 259, 179-184.
43. Sjogren, M.; Dahlstrom, M.; Hedner, E.; Jonsson, P.R.; Vik, A.; Gundersen, L-L.; Bohlin, L. Antifouling activity of the sponge metabolite agelasine D and synthesised analogs on Balanus improvisus. Biofouling 2008, 244, 251-258.
44. Atta-ur-Rahman; Choudhary, M.I. The Alkaloids; Brossi, A.; Ed.; Academic Press: New York, NY, USA, 1990; Volume 38, pp. 225-323.
45. Aniszewski, T. Alkaloids. In Secrets of Life; Elsevier: Amsterdam, The Netherland, 2007; pp. 237-286.
46. Christophersen, C. Marine Alkaloids. In The Alkaloids: Chemistry and Pharmacology; Brossi, A., Ed.; Academic Press Inc.: Orlando, FL, USA, 1985; Volume 24, pp. 25-111.
47. Appenzeller, J.; Mihci, G.; Martin, M-T.; Gallard, J-F.; Menou, J.-L.; Boury-Esnault, N.; Hooper, J.; Petek, S.; Chevalley, S.; Valentin, A. Agelasines J, K, and L from the Solomon Islands marine sponge Agelas cf. mauritiana. J. Nat. Prod. 2008, 71, 1451-1454.
48. Ohba, M.; Kawase, N.; Fujii, T. Total synthesis of (±)-agelasimine A, (±)-agelasimine B an (±)-purino-diterpene and the structure of diacetylagelasimin A. J. Am. Chem. Soc. 1996, 118, 8250-8257.
49. Ohba, M.; Iizuca, K.; Ishibashi, H.; Fujii, T. Synthesis and absolute configurations of marine sponge purines (+)-agelasimine A and (+)-agelasimine B. Tetrahedron 1997, 53, 16977-16986.
50. Medeiros, M.A.; Lourenco, A.; Tavares, M.R.; Curto, M.J. Marcelo, F.; Savluchinske, S.; Roseiro, J.C. (-)-Agelasidine A from Agelas clathrodes. Z. Naturforsch. C. J. Biosci. 2006, 61, 472-476.
51. Yosief, T.; Rudi, A.; Stein, Z.; Goldberg, I.; Garcia Gravalos, M. D.; Schleyer, M.; Kashman, Y. Asmarines A-C; three novel cytotoxic metabolites from the marine sponge Raspailia sp. Tetrahedron Lett. 1998, 39, 3323-3326.
52. Kimura, J.; Ishizuka, E.; Nakao, Y.; Yoshida, W.Y.; Scheuer, P.J.; Kelly-Borges, M. Isolation of 1-methylherbipoline salts of halisulfate-1 and of suvanine as serine protease inhibitors from a marine sponge, Coscinoderma mathewsi. J. Nat. Prod. 1998, 61, 248-250.
53. Mitchell, S.S.; Whitehill, A.B.; Trapido-Rosenthal, H.G.; Ireland, C.M. Isolation and characterization of 1,3-dimethylisoguanine from the Bermudian sponge Amphimedon viridis. J. Nat. Prod. 1997, 60, 727-728.
54. Tasdemir, D.; Mangalindan, G.C.; Concepcion, G.P.; Harper, M.K.; Ireland, C.M. 3,7-Dimethylguanine, a new purine from a Philippine sponge Zyzzya fuliginosa. Chem. Pharm. Bull. 2001, 49, 1628-1630.
55. Cafieri, F.; Fattorusso, Er.; Mangoni, A.; Taglialetela-Scafati, O. 3,7-Dimethylisoguanine, two novel alkaloids from the marine sponge Agelas longissima. Tetrahedron Lett. 1995, 36, 7893-7896.
56. Fuhrman, F.A.; Fuhrman, G.F.; Kim, Y.H.; Pavelki, L.A.; Mosher, H.S. Doridosine: A new hipotensive N-methylpurine riboside from the nudibranch Anisodoris nobilis. Science 1980, 207, 193-195.
57. Cullen, E.; Devlin, J.P. Agelasine, a novel quaternary 9-methyladenine from the sponge Agelas dispar. Can. J. Chem. 1975, 53, 1690-1691.
58. Fathi-Afshar, R.; Allen, T.M. Biological active metabolites from Agelas mauritania. Can. J. Chem. 1988, 66, 45-50.
59. Nakamura, H.; Wu, H.; Ohizumi, Y.; Hirata, Y. Physiologically active marine natural products from Porifera. IV. Agelasine A, B, C and D, novel bicyclic diterpenoids with a 9-methyladeninium unit possessing inhibitory effects on sodium-potassium ATPase from the Okinawan sea sponge Agelas sp. Tetrahedron Lett.1984, 25, 2989-2989.
60. Wu, H.; Nakamura, H.i; Kobayashi, J.; Kobayashi, M.; Ohizumi, Y.; Hirata, Y. Physiologically active marine natural products from Porifera. XII. Structures of agelasines, diterpenes having a 9-methyladeninium chromophore isolated from the Okinawan marine sponge Agelas nakamurai Hoshino. Bull. Chem. Soc. Jpn. 1986, 59, 2495-2504.
61. Fathi-Afshar, R.; Allen, T.M. Some pharmacological activities of novel adenine-related compounds isolated from a marine sponge Agelas mauritiana. Can. J. Physiol. Pharmacol. 1989, 67, 276-281.
62. Wu, H.; Nakamura, H.; Kobayashi, J.; Ohizumi, Y. Agelasine E and F, novel monocyclic diterpenoids with a 9-methyladeninium unit possessing inhibitory effects on Na,K-ATPase isolated from the Okinawian sea sponge Agelas nakamurai Hoshino. Tetrahedron Lett. 1984, 25, 3719-3722.
63. Mangalindan, G.C.; Talaue, M.T.; Cruz, L.J.; Franzblau, S. G.; Adams, L.B.; Richardson, A.D.; Ireland, C.M.; Concepcion, G.P. Agelasine F from a Philippine Agelas sp. sponge exhibits in vitro antituberculosis activity. Planta Med. 2000, 66, 364-365.
64. Hattori, T.; Adachi, K.; Shizuri, Y. New agelasine compound from the marine sponge Agelas mauritiana as an antifouling substance against macroalgae. J. Nat. Prod. 1997, 60, 411-413.
65. Fu, X.; Schmitz, F.J.; Tanner, R.S.; Kelly-Borges, M. Agelasines H and I, 9-methyladeninecontaining diterpenoids from an Agelas sponge. J. Nat. Prod. 1998, 61, 548-550.
66. Iwagawa, T.; Kaneko, M.; Okamura, H.; Nakatani, M.; Van S.; Rob W.M. New alkaloids from Paua New Guinea sponge Agelas nakamurai. J. Nat. Prod. 1998, 61, 1310-1312.
67. Pina, I.C.; Crews, P.; Tenney, K. A new agelasine derivative from the Caribbean sponge Agelas clathrodes. In Abstracts of Papers, 232nd ACS National Meeting, San Francisco, CA, USA, September 10-14, 2006.
68. Kashman, Y.; Rudi, A.; Yosief, T.; Gravalos, D.G. Cytotoxic alkaloid derivatives including asmarine A and B isolated from a sponge. PCT Int. Appl. WO 9933832 A1, 1999.
69. Rudi A.; Shalom H.; Schleyer M.; Benayahu Y.; Kashman Y. Asmarines G and H and barekol, three new compounds from the marine sponge Raspailia sp. J. Nat. Prod. 2004, 67, 106-109.
70. Rudi A.; Aknin M.; Gaydou E.; Kashman Y. Asmarines I, J, and K and nosyberkol: Four new compounds from the marine sponge Raspailia sp. J. Nat. Prod. 2004, 67, 1932-1935.
71. Roggen, H.; Gundersen, L-L. Synthetic studies directed towards agelasine analogs-synthesis, tautomerism, and alkylation of 2-substituted N-methoxy-9-methyl-9H-purin-6-amines. Eur. J. Org. Chem. 2008, 30, 5099-5106.
72. Piers, E.; Breau, M. L.; Han, Y.; Plourde, Guy, L.; Yeh, W-L. Total synthesis of cis-clerodane diterpenoids: (-)-Agelasine A and (+)-(3R,4S,5R,8S,9R,10S)-3, 4-epoxyclerod-13-en-15,16-olide. J. Chem. Soc., Perkin Trans. 1: Org. Bioorg. Chem. 1995, 8, 963-966.
73. Piers, E.; Roberge, J.Y. Total syntheses of the diterpenoids (-)-kolavenol and (-)-agelasine B. Tetrahedron Lett.1992, 33, 6923-6926.
74. Iio, H.; Asao, K.; Tokoroyama, T. Syntheses of agelasin B and its analogs. J. Chem. Soc., Chem. Com. 1985, 774-775.
75. Asao, K.; Monden, M.; Asada, T.o; Iio, H.; Tokoroyama, T. Synthetic studies on clerodane diterpenoids. Asymmetric synthesis of (-)-kolavenic acid and synthesis of agelasins. Tennen Yuki Kagobutsu Toronkai Koen Yoshishu 1985, 27th, 137-143.
76. Marcos, I. S.; Garcia, N.; Sexmero, M.J.; Basabe, P.; Diez, D.; Urones, J.G. Synthesis of (+)-agelasine C. A structural revision. Tetrahedron 2005, 61, 11672-11678.
77. Utenova, B.T.; Gundersen, L.-L. Synthesis of (+)-agelasine D from (+)-manool. Tetrahedron Lett. 2004, 45. 4233-4235.
78. Vik, A.; Hedner, E.; Colin, C.; Samuelsen, O.; Larsson, R.; Gundersen, L-L.; Bohlin, L. (+)-Agelasine D: Improved synthesis and evaluation of antibacterial and cytotoxic activities J. Nat. Prod. 2006, 69, 381-386.
79. Bakkestuen, A.K.; Gundersen, L-L. Synthesis of (+)-trixagol and its enantiomer, the terpenoid side chain of (-)-agelasine E. Tetrahedron 2003, 59, 115-121.
80. Proszenyak, A.; Braendvang, M.; Charnock, C.; Gundersen, L-L. The first synthesis of ent-agelasine F. Tetrahedron 2009, 65, 194-199.
81. Proszenyak, A.; Charnock, C.; Hedner, E.; Larsson, R.; Bohlin, L.; Gundersen L-L. Synthesis, antimicrobial and antineoplastic activities for agelasine and agelasimine analogs with a betacyclocitral derived substituent. Arch. Pharm. 2007, 340, 625-34.
82. Mancini, I.; Defant, A.; Guella, G. Recent synthesis of marine natural products with antibacterial activities. Anti-Infect. Agents Med. Chem. 2007, 6, 17-48.
83. Vik, A.; Gundersen, L-L. Synthetic studies directed towards asmarines; construction of the tetrahydrodiazepinopurine moiety by ring closing metathesis. Tetrahedron Lett. 2007, 48, 1931-1934.
84. Ohba, M.; Tashiro, T. Preparatory study for the synthesis of the marine sponge alkaloids asmarines A-F: Synthesis of their heterocyclic portions. Heterocycles 2002, 57, 1235-1238.
85. Pappo, D.; Kashman, Y. Synthesis of 9-substituted tetrahydrodiazepinopurines-asmarine A analogues. Tetrahedron 2003, 59, 6493-6501.
86. Rodgen, S.A.; Schaus, S.E. Efficient construction of the clerodane decalin core by an asymmetric Morita-Baylis-Hillman reaction/Lewis acid promoted annulation strategy. Ang. Chem., Int. Ed. 2006, 45, 4929-4932.
87. Rodgen, S.A.; Schaus, S.E. Total synthesis of Asmarine B. In Abstracts of Papers, 234th ACS National Meeting, Boston, MA, USA, August 19-23, 2007.
88. Pappo, D.; Rudi, A.; Kashman, Y. A synthetic approach towards the synthesis of asmarine analogues. Tetrahedron Lett. 2001, 42, 5941-5943.
89. Zhang, F-L.; Vasella, A. Synthesis of spiropyrimidodiazepines and spirodiazepinopurines by tandem nitroso-ene/Diels-Alder reactions. Helv. Chim.Acta 2007, 90. 2315-2329.
90. Clare, A.S. Towards non-toxic antifouling. J. Mar. Biotechnol. 1998, 6, 3-6.
91. Nikomenko, B.V.; Protopopova, M.; Samala, R.; Einck, I.; Nacy, C.A. Drug therapy of experimental tuberculosis (tb): Improved outcome by combining SQ109, a new diamine antibiotic, with existing TB drugs. Antimicrob. Agents Chemother. 2007, 51, 1563-1565.
92. Copp, B.R. Pearce, A.N. Natural product growth inhibitors of Mycobacterium tuberculosis. Nat. Prod. Rep. 2007, 24, 278-297.
93. Kishore, N.; Mishra, B.B.; Tripathi, V.; Tiwari, V.K. Alkaloids as potential antitubercular agents. Fitoterapia 2009, 80, 149-163.
94. Palomino, J,C.; Ramos, D.F.; da Silva, P.A. New anti-tuberculosis drugs: Strategies, sources and new molecules. Curr. Med. Chem. 2009, 16, 1898-1904.
95. Alksnis, E.; Korneeva, D.; Lukevics, E. Adenine and uracil derivatives with antitubercular activity. Chem. Het. Com. 2001, 37, 743-746.
96. Cos, P.; Vlietinck, A.J.; Berghe, D.V.; Maes, L. Anti-infective potential of natural products: How to develop a stronger in vitro 'proof-of-concept'. J. Ethnopharmacol. 2006, 106, 290-302.
97. Gademann, K.; Kobylinska, J. Antimalarial natural products of marine and freshwater origin Chem. Rec. 2009, 9, 187-198.
98. Nakamura, H.; Kobayashi, J.; Wu, H.; Deng, S.; Kobayashi, M.; Nakamura, Y.; Ohizumi, Y.; Hirata, Y. Enzyme inhibitors isolated from Okinawan marine sponges. Tennen Yuki Kagobutsu Toronkai Koen Yoshishu 1985, 27, 608-615.
99. Lio, H.; Asao, K.; Tokoroyama, T. Syntheses of agelasin B and its analogues. J. Chem. Soc., Chem. Commun. 1985, 774-775.
100. Tao, P.-L.; Yen, M.-H.; Shyu, W.-S.; Chern, J.-W. Doridosine derivatives: Binding at adenosine receptors and in vivo effect. Eur. J. Pharmacol. 1993, 243, 135-139.
101. Fossa, P.; Mosti, L.; Bondavalli, F.; Schenone, S.; Ranise, A.; Casolino, C.; Forina, M.. Affinity prediction on A1 adenosine receptor agonists: The chemometric approach. Bioorg. Med. Chem. 2006, 14, 1348-1363.